RE:Waiting...You know what.. When investors were waiting to hear about results from ONCY's first Phase III trail for head & Neck cancers, Brtad Thomson (then CEO), reassured investors that the survival curve was still progressing... and I think results were 12 months later than anticipated.
From the numbers previously presented, in essence the company was waiting on data from just one or two patients.
Brad's comments were... patients just keep living longer and longer. The longer the wait the better the results... was his mantra.
And, can you guess what happened with the results from the Phase III, that ONCY claimed was successful..? Hmmmm, let's just hope history isn't repeating eh... cause right now, all we have is hope.. and that is a dangerous place to be as an investor.